Kaempferol attenuates the development of diabetic neuropathic pain in mice: Possible anti-inflammatory and anti-oxidant mechanisms

Macedonian Journal of Medical Sciences

Volumn 7, Issue 3, 2014, Pages 424-430

  Abo Salem, Osama M ^a,b  

^a TAIF UNIVERSITY   (Saudi Arabia)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Cytokines; Diabetic neuropathy; Kaempferol; Oxidative; Stress

Indexed keywords

GLUCOSE; GLUTATHIONE; INTERLEUKIN 1BETA; KAEMPFEROL; MALONALDEHYDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLD ALLODYNIA; CONTROLLED STUDY; DIABETIC NEUROPATHY; EXPERIMENTAL BEHAVIORAL TEST; FORMALIN INDUCED PAIN AND EDEMA TEST; HOT PLATE TEST; LIPID PEROXIDATION; MALE; MOUSE; NEUROPATHIC PAIN; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PAW IMMERSION TEST; TAIL IMMERSION TEST; WEIGHT GAIN;

EID: 84908215750     PISSN: 18575749     EISSN: 18575773     Source Type: Journal    
DOI: 10.3889/MJMS.1857-5773.2014.0401     Document Type: Article

References (44)

1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54: 1615-1625.
2. Stevens MJ. Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes. 2000; 49:1006-1015.
3. Quan Y et al. High glucose stimulates GRO secretion from rat microglia via ROS, PKC, and NF-kappaB pathways. J Neurosci Res. 2007; 85: 3150-3159.
4. Kellogg AP, Pop-Busui R. Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress. Antioxid Redox Signal. 2005; 7: 1521-9.
5. Drel VR et al. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur J Pharmacol. 2007; 569: 48-58.
6. Conti G et al. Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitantwith endoneurial induction of IL-1beta and p75NTR. J Neurol Sci. 2002; 195: 35-40.
7. Skundric DS, Lisak RP. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Exp Diabesity Res. 2003; 4: 303-312.
8. Raghavendra V et al. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther. 2003; 306: 624-630.
9. Daulhac L et al. Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartatedependent mechanisms. Mol Pharmacol. 2006; 70: 1246-1254.
10. Krady JK et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in rodent model of diabetic retinopathy. Diabetes. 2005; 54: 1559-1565.
11. Luo Y et al. Neuronal and glial response in the rat hypothalamus neurohypophysis complex with streptozotocin-induced diabetes. Brain Res. 2002; 925: 42-54.
12. Li J et al. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci. 2005; 102: 9936-9941.
13. Candelario-Jalil E et al. Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinflammation. 2007; 4: 25-31.
14. Ledeboer A et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain. 2005; 115: 71-83.
15. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against Nmethyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol. 2001; 166: 7527-7533.
16. Wong MC et al. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ. 2007; 335: 87-94.
17. Calderon-Montano JM et al. Areview on the dietary flavonoid kaempferol. Mini Rev Med Chem. 2011; 11(4): 298-344.
18. Anjaneyulu M, Chopra K. Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice. Eur J Pharmacol. 2004; 497: 285-92.
19. Li S, Pu XP. Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Biol Pharm Bull. 2011; 34(8): 1291-6.
20. Zhang Y, Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol. 2011; 670(1): 325-32.
21. Parveen Z et al. Antiinflammatory and analgesic activities of Thesium chinense Turcz extracts and its major flavonoids, kaempferol and kaempferol-3-O-glucoside. Yakugaku Zasshi. 2007; 127(8): 1275-9.
22. De Melo GO et al. Antinociceptive and anti-inflammatory kaempferol glycosides from Sedum dendroideum. J Ethnopharmacol. 2009; 124(2): 228-32.
23. Padi SSV, Kulkarni SK. Differential effects of naproxen and rofecoxib on the development of hypersensitivity following nerve injury in rats. Pharmacol Biochem Behav. 2004; 79: 349-358.
24. Calcutt NA et al. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain. 1996; 68: 293-9.
25. Padi SSV et al. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor. Eur J Pharmacol. 2004; 491: 69-76.
26. Abo-Salem OM et al. Antinociceptive effects of novel A2B adenosine receptor antagonists. J Pharmacol Exp Ther. 2004; 308: 358-366.
27. Bilkei-Gorzo A et al. Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia. Naunyn-Schmiedeberg_s Arch Pharmacol. 2008; 377: 65-76.
28. Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst. 1972; 97: 142-149.
29. Abrams JS. Immunoenzymatic assay of cytokines using NIP-labeled antibodies. In: Current Protocols in Immunology, (ed). J. Coligan, A. Kruisbeck, D. Margulies, E. Shevach and W. Strober. John Wiley & Sons: New York, 1995: 620-680.
30. Hortelano S et al. Nitric oxide is released resulting in regenerating liver after partial hepatectomy. Hepatol. 1995; 21: 776-786.
31. Draper HH, Hadley M. Methods in Enzymology, Academic Press: New York, 1990: 421-455.
32. Ellman MA. Spectrophotometric method for determination of reduced glutathione in tissues. Analyt Biochem. 1959; 74: 214-226.
33. Yagihashi S et al. Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes Res Clin Pract. 2007; 77: 184-189.
34. Abo-Salem OM et al. Experimental diabetic nephropathy can be prevented by propolis: effect on metabolic disturbances And renal oxidative parameters. Pak J Pharm Sci. 2009; 22(2): 205-210.
35. Faux SP, Howden PJ. Possible role of lipid peroxidation in the induction of NF-kappa B and AP-1 in RFL-6 cells by crocidolite asbestos: evidence following protection by vitamin E. Environ Health Perspect. 1997; 105: 1127-30.
36. Sharma S et al. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNFalpha. Phytother Res. 2007; 21: 278-83.
37. Liang YC et al. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 1999; 20: 1945-1952.
38. Lagoa R et al. Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid. J Neurochem. 2009; 111(2): 473-87.
39. Park SE et al. Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells. Br J Pharmacol. 2011; 164(3): 1008-25.
40. Bal-Price A, Brown GC. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci. 2001; 21: 6480-6491.
41. Thacker MA et al. Pathophysiology of peripheral neuropathic pain: Immune cells and molecules. Anesth Analg. 2007; 105: 838-847.
42. Kowalski J et al. Effect of kaempferol on the production and gene expression of monocyte chemoattractant protein-1 in J774.2 macrophages. Pharmacol Rep. 2005; 57: 107-112.
43. Chen X et al. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice. Int Immunopharmacol. 2012; 14(2): 209-16.
44. Narita M et al. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem. 2006; 97: 1337-1348.